We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
William Annett joined as CEO in June 2015. His experience includes CEO of BioFX Laboratories, Inc., an in vitro diagnostic company successfully sold to a large life sciences company. He founded and led Corra Life Sciences, a prenatal diagnostics company. He also founded a consumer products company that became publicly traded on NASDAQ during his tenure as CEO. At Genentech, Mr. Annett led the Commercial Strategy group, managed large operational projects, and directed the Project Finance function, which supported all pipeline products with more than 200 clinical trials. Most recently, he was a Managing Director at Accenture heading the West Coast Life Sciences practice with sales, marketing, and delivery responsibilities. His clients included most of the major biotech and pharmaceutical companies in the western US. He is a member of the Board of Directors of the California Life Sciences Association.
This speaker's sessions: